Brain type carnosinase in dementia: A pilot study

BMC Neurology

Volumn 7, Issue , 2007, Pages

  Balion, Cynthia M ^a,b   Benson, Carolyn ^a,b   Raina, Parminder S ^a,b   Papaioannou, Alexandra ^b   Patterson, Christopher ^a,b   Ismaila, Afisi S ^b  

^a Hamilton Health Sciences ^*  (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN TYPE CARNOSINASE; DIPEPTIDASE; DONEPEZIL; GALANTAMINE; MEMANTINE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CARNOSINE; CNDP1 PROTEIN, HUMAN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME SUBSTRATE; EXERCISE; FEMALE; FLUOROMETRY; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; MIXED DEMENTIA; NEUROIMAGING; PATHOPHYSIOLOGY; PILOT STUDY; BLOOD; BRAIN; METABOLISM; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; ONSET AGE; PHYSIOLOGY; PREDICTION AND FORECASTING;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; BRAIN; CARNOSINE; DEMENTIA; DIPEPTIDASES; EXERCISE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS;

EID: 38349054020     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-7-38     Document Type: Article

References (50)

1. Blennow K Vanmechelen E CSF markers for pathogenic processes in Alzheimer's disease: Diagnostic implications and use in clinical neurochemistry [Review] Brain Res Bull 2003, 61:235-42. 10.1016/ S0361-9230(03)00086-8 12909293
2. Boss MA Diagnostic approaches to Alzheimer's disease [Review] Biochim Biophys Acta 2000, 1502:188-200. 10899443
3. Gupta A Watkins A Thomas P Majer R Habubi N Morris G Pansari K Coagulation and inflammatory markers in Alzheimer's and vascular dementia Int J Clin Pract 2005, 59:52-7. 10.1111/ j.1742-1241.2004.00143.x 15707465
4. Bièíková M Řípová D Hill M Jirák Havlikova H Tallova J Hampl R Plasma level of 7-hydroxylated dehydroepiandrosterone (DHEA) metabolites and selected amino-thiols as discriminatory tools of Alzheimer's disease and vascular dementia Clin Chem Lab Med 2004, 42:518-24. 10.1515/CCLM.2004.088 15202788
5. Takahasi M Stanton E Moreno JI Jackowki G Immunoassay for serum glutamine synthetase in serum: Development, reference values, and preliminary study in dementias Clin Chem 2002, 48:375-8. 11805026
6. Irizarry MC Biomarkers of Alzheimer disease in plasma NeuroRx 2004, 1:226-34. 534932 15717023 10.1602/neurorx.1.2.226
7. Dantoine TF Debord J Merle L Lacroix-Ramiandrisoa H Bourzeix L Charmes J-P Paraoxonase 1 activity: A new vascular marker of dementia Ann NY Acad Sci 2002, 977:96-101. 12480737
8. Teufel M Saudek V Ledig J Bernhardt A Boularand S Carreau A Cairns NJ Carter C Cowley DJ Duverger D Ganzhorn AJ Guenet C Heintzelmann B Laucher V Sauvage C Smirnova T Sequence identification and characterization of human carnosinase and a closely related non-specific dipeptidase J Biol Chem 2003, 278:6521-31. 10.1074/jbc.M209764200 12473676
9. Quinn PJ Boldyrev AA Formazuyk VE Carnosine properties, functions and potential therapeutic applications [Review] Mol Aspects Med 1992, 13:379-44. 10.1016/0098-2997(92)90006-L 9765790
10. Szwergold BS Carnosine and anserine act as effective transglycating agents in decomposition of aldose-derived Schiff bases Biochem Biophys Res Commun 2005, 336:36-41. 10.1016/j.bbrc.2005.08.033 16112643
11. Munch G Gerlach M Sian J Wong A Riederer P Advanced glycation end products in neurodegeneration: More than early markers of oxidative stress? [Review] Ann Neurol 1998, 44:S85-8. 9749578
12. Dukic-Stefanovic S Schinzel R Reiderer R Münch G AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs Biogerontology 2001, 2:19-34. 10.1023/A:1010052800347 11708614
13. Holliday R McFarland GA A role for carnosine in cellular maintenance Biochemistry (Mosc) 2000, 65:873-88. 11002180
14. Shao L Li Q-H Tan Z L-Carnosine reduces telomere damage and shortening rate in cultured normal fibroblasts Biochem Biophys Res Comm 2004, 24:931-6. 10.1016/j.bbrc.2004.09.136
15. Trombley PQ Horning MS Blakemore LJ Carnosine modulates zinc and copper effects on amino acid receptors and synaptic transmission NeuroReport 1998, 9:3503-7. 10.1097/00001756-199810260-00031 9855307
16. Perry G Castellani RJ Smith MA Harris PL Kubat Z Ghanbari K Jones PK Cordone G Tabaton M Wolozin B Ghanbari H Oxidative damage in the olfactory system in Alzheimer's disease Acta Neuropathol 2003, 106:552-6. 10.1007/s00401-003-0761-7 12955399
17. Lovell MA Robertson JD Teesdale WJ Campbell JL Markesbery WR Copper, iron and zinc in Alzheimer's disease senile plaques J Neurol Sci 1998, 158:47-52. 10.1016/S0022-510X(98)00092-6 9667777
18. Trombley PQ Horning MS Blakemore LJ Interactions between carnosine and zinc and copper: Implications for neuromodulation and neuroprotection [Review] Biochemistry (Mosc) 2000, 65:807-16. 10951099
19. Lanctot KL Herrmann N Mazzotta P Khan LR Ingber N GABAergic function in Alzheimer's disease: Evidence for dysfunction and potential as a therapeutic target for the treatment of behavioural and psychological symptoms of dementia Can J Psychiatry 2004, 49:439-53. 15362248
20. Mazurkiewicz-Kwilecki IM Nsonwah S Changes in the regional brain histamine and histidine levels in postmortem brains of Alzheimer patients Can J Physiol Pharmacol 1989, 67:75-8. 2713757
21. Cohen M Hartlage PL Krawiecki N Roesel RA Carter AL Hommes FA Serum carnosinase deficiency: A non-disabling phenotype J Ment Defic Res 1985, 29:383-9. 4093964
22. Lunde HA Gjessing LR Sjaastad O Homocarnosinosis: Influence of dietary restriction of histidine Neurochem Res 1986, 11:825-38. 10.1007/ BF00965207 3736769
23. Butterworth RJ Wassif WS Sherwood RA Gerges A Poyser KH Garthwaite J Peters TJ Bath PM Serum neuron-specific enolase, carnosinase, and their ratio in acute stroke. An enzymatic test for predicting outcome? Stroke 1996, 27:2064-8. 8898817
24. Wassif WS Sherwood RA Amir A Idowu B Summers B Leigh N Peters TJ Serum carnosinase activities in central nervous system disorders Clin Chim Acta 1994, 225:57-64. 10.1016/0009-8981(94)90027-2 8033354
25. Schoen P Everts H de Boer T van Oeveren W Serum carnosinase activity in plasma and serum: Validation of a method and values in cardiopulmonary bypass surgery [Technical Brief] Clin Chem 2003, 49:1930-2. 10.1373/ clinchem.2003.019398 14578326
26. Chorsky RL Yaghmai F Hill WD Stopa EG Alzheimer's disease: A review concerning immune response and microischemia [Review] Med Hypotheses 2001, 56:124-7. 10.1054/mehy.2000.1148 11133269
27. Ishii K Kitagaki H Kono M Mori E Decreased medial temporal oxygen metabolism in Alzheimer's disease shown by PET J Nucl Med 1996, 37(7):1159-1165. 8965188
28. Ririe DG Roberts PR Shouse MN Zaloga GP Vasodilatory actions of the dietary peptide carnosine Nutrition 2000, 16:168-72. 10.1016/ S0899-9007(99)00268-3 10705070
29. McDowell I Kristjansson B Hill G Hébert R Community screening of dementia: The Mini-Mental State Exam (MMSE) and Modified Mine-Mental State Exam compared J Clin Epidemiol 1997, 50:377-83. 10.1016/ S0895-4356(97)00060-7 9179095
30. McKhann G Drachman DA Folstein M Katzman R Price D Stadlan EM Clinical diagnosis of Alzheimer's disease-report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease Neurology 1984, 34:939-44. 6610841
31. Lenney JF George RP Weiss AM Kucera CM Chan PWH Rinzler GS Human serum carnosinase: Characterization, distinction from cellular carnosinase, and activation by cadmium Clin Chim Acta 1982, 123:221-31. 10.1016/ 0009-8981(82)90166-8 7116644
32. Ambrose JA Crimm A Burton J Paullin K Ross C Fluorometric determination of histidine Clin Chem 1969, 15:361-6. 5783790
33. Balion CM Regulation of carnosine metabolism: Carnosinase in rat tissues and human sera [MSc thesis] Saskatoon, Canada: University of Saskatchewan 1990
34. Jellinger KA Alzheimer disease and cerebrovascular pathology: An update [Review] J Neural Transm 2002, 109:813-36. 10.1007/s007020200068 12111471
35. Holdenrieder S Lütjohann D Geiger S von Bergmann K Stieber P Hamann GF Does brain specific 24 S-hydroxycholesterol in plasma indicate the disruption of the blood-brain barrier in patients with ischemic stroke? Neurosci Lett 2005, 368:201-4. 10.1016/j.neulet.2004.07.012
36. Kirk J Plumb J Mirakhur M McQuaid S Tight junctional abnormality in multiple sclerosis whitematter affects all calibres of vessel and its associated blood-brain barrier leakage and active demyelination J Pathol 2003, 201:319-27. 10.1002/path.1434 14517850
37. Skoog I Wallin A Fredman P Hesse C Aevarsson O Karlsson I Gottfries CG Blennow K A population study on blood-brain barrier function in 85-year-olds: Relation to Alzheimer's disease and vascular dementia Neurology 1998, 50:966-71. 9566380
38. Kumar-Singh S Pirici D McGowan E Serneels S Ceuterick C Hardy J Duff K Dickson D Van Broeckhoven C Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls Am J Pathol 2005, 167:527-43. 1603563 16049337
39. Willi SM Zhang Y Hill JB Phelan MC Michaelis RC Holden KR A deletion in the long arm of chromosome 18 in a child with serum carnosinase deficiency Pediatr Res 1997, 41:210-3. 10.1203/00006450-199702000-00009 9029640
40. Lee JH Mayeux R Mayo D Mo J Santana V Williamson J Flaquer A Ciappa A Rondon H Estevez P Lantigua R Kawarai T Toulina A Medrano M Torres M Stern Y Tycko B Rogaeva E George-Hyslop P Knowles JA Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics Mol Psychiatry 2004, 9:1042-51. 1578737 15241431 10.1038/sj.mp.4001538
41. Janssen B Hohenadel D Brinkkoetter P Peters V Rind N Fischer C Rychlik I Cerna M Romzova M de Heer E Baelde H Bakker SJ Zirie M Rondeau E Mathieson P Saleem MA Meyer J Koppel H Sauerhoefer S Bartram CR Nawroth P Hammes HP Yard BA Zschocke J van der Woude FJ Carnosine as a protective factor in diabetic nephropathy Association with leucine repeat of the carnosinase gene CNDP1 Diabetes 2005, 54:2320-7. 10.2337/ diabetes.54.8.2320 16046297
42. Munzar M Levy S Rush R Averback P Clinical study of a urinary competitive ELISA for neural thread protein in Alzheimer disease Neurol Clin Neurophysiol 2002, 2002:2-8. 10.1162/15268740252769709 12028823
43. Larson EB Wang L Bowen JD McCormick WC Teri L Crane P Kukull W Exercise associated with reduced risk for incident dementia among persons 65 years of age and older Ann Intern Med 2006, 144:73-81. 16418406
44. Ledig J-P Vladimir S Human carnosinase 2 EP 1122307, Aug 18, 2001
45. van Munster PJJ Trijbels JMF van Heeswijk PJ Schut-Jansen B Moerkerk C A new sensitive method for the determination of serum carnosinase activity using L-carnosine-[I-14C]β-alanyl as substrate Clin Chim Acta 1970, 29:243-8. 10.1016/0009-8981(70)90043-4 5493180
46. Orfanos AP Guthrie R Jinks DC A fluorometric micromethod for estimation of carnosinase in dried blood samples Clin Chim Acta 1987, 166:219-25. 10.1016/0009-8981(87)90424-4 3621601
47. Chertkow H Bergman H Schipper HM Gauthier S Bouchard R Fontaine S Clarfield AM Assessment of suspected dementia Can J Neurol Sci 2001, 28(Suppl 1):S28-S41. 11237308
48. Mendez MF Mastri AR Zander BA Frey WH 2nd A clinicopathological study of CT scans in Alzheimer's disease J Am Geriatr Soc 1992, 40(2):476-478. 1634700
49. Bowen JD Kamin R Leverenz JB Fishel MA McCormick WC Kukull WA Larson EB Interrater reliability and accuracy in identifying ischemic strokes using computed tomography scans in people with dementia J Am Geriatr Soc 2005, 53(10):1743-1747. 16181174
50. Kurita A Black RS Blass JP Deck MD Nolan KA Failure of CT scan to detect ischemic lesions in patients with dementia J Geriatr Psychiatry Neurol 1993, 6(4):245-250. 8251055